factual

First-Mover Advantage Is Channel Not Algorithmic

A genomic prediction company's defensible advantage lies primarily in the business-channel relationships and trust built with IVF clinics worldwide rather than in a permanent scientific moat, since a competitor with much more data (like 23andMe) could in principle build better predictors—though sustained focus and expertise still make a market leader hard to beat.

factualpending

Speaker

Steve Hsu

Evidence Quote

“It may not be a defensible, purely scientific moat around the company... this general idea of who will best predict human traits from DNA? It's unclear who's going to be the winner in that race.”

Source

Steve Hsu - Intelligence, Embryo Selection, & The Future of Humanity— Dwarkesh Patel Podcast
Created: 6/13/2026, 3:37:09 AM

Your notes

Loading notes...